The Product Stewardship Society (PSX) will host the PSX 2021 in Anaheim, CA, on September 28-30. The conference covers a variety of challenges and opportunities related to product stewardship and provides information and knowledge for certification. The range of topics includes emerging trends for product safety and regulatory professionals; per- and polyfluoroalkyl substances (PFAS) in products: emerging compliance, challenges, and solutions; understanding the Environmental Protection Agency’s (EPA's) significant new use rule for long-chain perfluoroalkyl carboxylates (LCPFACs); in pursuit of sustainability: the intersection of US and EU policies; and moving from analysis paralysis to action in product stewardship.
Sarahann Marie (Dow) Rackl, Ph.D., P.E., Exponent senior manager, and Andrew J. Worthen, Ph.D., P.E., Exponent managing engineer, will speak on “Fluorinated Chemicals and Challenges to Product Stewardship” during a session moderated by Sarah E. Parker, Ph.D., Exponent managing scientist, on Tuesday, September 28, at 4:15 PM-5:15 PM PT/1:15 PM-2:15 PM ET. Their session will help participants understand current compliance and product stewardship challenges relating to fluorinated chemicals. The speakers will cover fluorinated chemical terminology, considerations for product testing, and tips to avoid pitfalls associated with consumer product testing.
On Wednesday, September 29, at 2:45 PM–3:15 PM PT/11:45 AM-12:15 PM ET, Ryan C. Lewis, Ph.D., CIH, Exponent managing scientist, will discuss “Scientific Considerations for Communicating Risks Associated with Talc” during a session moderated by Sarah Dahlberg, M.S., Exponent scientist. Drawing upon the most up-to-date scientific information available, this session will discuss communicating risk to stakeholders and making risk management decisions if serpentine or amphibole materials are detected in talc-containing products, which can potentially elevate end users' risk of mesothelioma through inhalation exposures. Specifically, Dr. Lewis will cover four scientific considerations related to mesothelioma risks: the epidemiology of mesothelioma among talc-exposed cohorts; the distinction of mesothelioma hazard between and within mineral types and habits; quantitative contextualization of analytical content data with relevant benchmarks; and influence of encapsulation and matrix effects on the release of these minerals.
In addition, Renee M. Kalmes, MSPH, CIH, Exponent principal scientist and office director; Callan Krevanko, Exponent scientist; and Keith Morris-Schaffer, Ph.D., Exponent senior scientist, will be speaking on “Quickly Resolving Compliance Issues for Large Product Lines” during a session moderated by Alison Gauthier, MSPH, CIH, CPPS, Exponent managing scientist, on Thursday, September 30, at 8:30 AM-9:30 AM PT/5:30 AM-6:30 AM ET. The speakers will present risk assessment case scenarios that resolve critical compliance issues within large product lines, including reviewing the benefits and challenges of establishing internal target compliance limits, their health implications, and implementation issues in the initial stage of risk assessments. They will also discuss best practices for exposure and risk assessments using several case studies, including alternative testing methods and simulation techniques that could serve as the basis for defensible and conclusive reports.
For more information, click here.